uPA Inhibitor II, UK122 from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

uPA Inhibitor II, UK122 Chemicals

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
uPA Inhibitor II, UK122

Description

uPA Inhibitor II, UK122

Product Specs
ItemuPA Inhibitor II, UK122
CompanySanta Cruz Biotechnology, Inc.
Price $360.00Supplier Page View Company Product Page
Catalog Numbersc-356185
Quantity5 mg
TypeBiochemical Reagents
Molecular Weight405.33

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Urokinase-type plasminogen activator blockade ameliorates experimental colitis in miceScientific reportsFebruary 18, 2023Kida Y, Okahisa T, Sato Y, Bando M, Fujimoto S, Ma B, Nakagawa T, Kawaguchi T, Nakamura F, Okamoto K, et al.

(2) Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/BRAF/TAK1/ERK/ETV4 signalingCancer biology & medicineOctober 9, 2021Ma P, Jin X, Fan Z, Wang Z, Yue S, Wu C, Chen S, Wu Y, Chen M, Gu D, et al.TX, USA). Belvarafenib (S8853) was purchased from Selleck Chemicals (Houston, TX, USA), and UK122 (sc-356185) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). RNA isolation and quantitative real-time PCR

(3) Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cellsCell death & diseaseAugust 9, 2019Willbold R, Wirth K, Martini T, Sültmann H, Bolenz C, Wittig R.

(4) Discovery and SAR of Novel and Selective Inhibitors of Urokinase Plasminogen Activator (uPA) with an Imidazo[1,2-a]pyridine ScaffoldJournal of medicinal chemistryDecember 10, 2015Gladysz R, Adriaenssens Y, De Winter H, Joossens J, Lambeir AM, Augustyns K, Van der Veken P.

(5) HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer ProgressionFrontiers in oncologyJanuary 1, 2015Mirzapoiazova T, Mambetsariev N, Lennon FE, Mambetsariev B, Berlind JE, Salgia R, Singleton PA.

Be the First to Write a Review!